Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-Current Deferred Tax Liability (2021 - 2022)

Neuroone Medical Technologies' Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $140538.0 for Q3 2022.

  • For Q3 2022, Non-Current Deferred Tax Liability rose 118.94% year-over-year to $140538.0; the TTM value through Sep 2022 reached $140538.0, up 118.94%, while the annual FY2022 figure was $140538.0, 118.94% up from the prior year.
  • Non-Current Deferred Tax Liability reached $140538.0 in Q3 2022 per NMTC's latest filing, up from $64189.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $140538.0 in Q3 2022 to a low of $64189.0 in Q3 2021.